Is dextrose prolotherapy beneficial in the management of temporomandibular joint internal derangement? A systematic review

References

• McNeill C. Management of temporomandibular disorders: concepts and controversies. J Prosthet Dent. 1997 May;77(5):510–522.
   PubMed Web of Science ®Google Scholar
• De Leeuw R. Internal derangements of the temporomandibular joint. Oral Maxillofac Surg Clin North Am. 2008;20(2):159–168.
   PubMedGoogle Scholar
• Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the international RDC/TMD consortium network and orofacial pain special interest group. J Oral Facial Pain Headache. 2014;28(1):6–27. DOI:10.11607/jop.1151
   PubMed Web of Science ®Google Scholar
• Yap AU, Zhang MJ, Cao Y, et al. Comparison of psychological states and oral health–related quality of life of patients with differing severity of temporomandibular disorders. J Oral Rehabil. 2022 Feb;49(2):177–185.
   PubMed Web of Science ®Google Scholar
• Türp JC, Motschall E, Schindler HJ, et al. In patients with temporomandibular disorders, do particular interventions influence oral health‐related quality of life? A qualitative systematic review of the literature. Clin Oral Implants Res. 2007 Jun;18(3):127–137.
   PubMedGoogle Scholar
• Hosgor H, Bas B, Celenk C. A comparison of the outcomes of four minimally invasive treatment methods for anterior disc displacement of the temporomandibular joint. Int J Oral Maxillofac Surg. 2017;46(11):1403–1410.
   PubMed Web of Science ®Google Scholar
• Santacatterina A, Paoli M, Peretta R, et al. A comparison between horizontal splint and repositioning splint in the treatment of ‘disc dislocation with reduction’. Lit Meta-Analysis J Oral Rehabil. 1998;25(2):81–88.
   PubMedGoogle Scholar
• Conti PC, Miranda JE, Conti AC, et al. Partial time use of anterior repositioning splints in the management of TMJ pain and dysfunction: a one-year controlled study. J Appl Oral Sci. 2005;13(4):345–350.
   PubMedGoogle Scholar
• Conti PC, Corrêa AS, Lauris JR, et al. Management of painful temporomandibular joint clicking with different intraoral devices and counseling: a controlled study. J Appl Oral Sci. 2015;23(5):529–535.
   PubMed Web of Science ®Google Scholar
• Madani AS, Mirmortazavi A. Comparison of three treatment options for painful temporomandibular joint clicking. J Oral Sci. 2011;53(3):349–354.
   PubMedGoogle Scholar
• Summer JD, Westesson PL. Mandibular repositioning can be effective in treatment of reducing TMJ disk displacement. A long-term clinical and MR imaging follow-up. CRANIO®. 1997;15(2):107–120.
   Web of Science ®Google Scholar
• Rodhen RM, de Holanda TA, Barbon FJ, de Oliveira da Rosa WL, Boscato N. Invasive surgical procedures for the management of internal derangement of the temporomandibular joint: a systematic review and meta-analysis regarding the effects on pain and jaw mobility. Clin Oral Investig. 2022 Apr;26(4):3429–3446.
   PubMedGoogle Scholar
• Schultz LW. A treatment for subluxation of the temporomandibular joint. JAMA 1937 Sep 25;109(13):1032–1035.
   Google Scholar
• Reeves KD. Prolotherapy: basic science, clinical studies, and technique. In: Lennard TD, editor. Pain procedures in clinical practice. 2nd ed. Philadelphia, PA: Hanley and Belfus; 2000. pp. 172–190.
   Google Scholar
• DeChellis DM, Cortazzo MH. Regenerative medicine in the field of pain medicine: prolotherapy, platelet-rich plasma, and stem cell therapy-theory and evidence. Tech Reg Anesth Pain Manag. 2011;15:74–80.
   Google Scholar
• Rabago D, Slattengren A, Zgierska A. Prolotherapy in primary care practice. Prim Care. 2010;37:65–80.
   PubMed Web of Science ®Google Scholar
• Thorens B, Mueckler M. Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab. 2010;298:E141–5.
   PubMed Web of Science ®Google Scholar
• Mahmoud NR. Sodium hyaluronic acid, platelet rich plasma and dextrose prolotherapy in management of Temporo-mandibular joint internal derangement. A comparative study. Egypt Dent J 2018 Apr 1;64(2–April (Oral Surgery):1055–1069.
   Google Scholar
• Fouda AA. Change of site of intra-articular injection of hypertonic dextrose resulted in different effects of treatment. Br J Oral Maxillofac Surg 2018 Oct 1;56(8):715–718.
   PubMedGoogle Scholar
• Louw WF, Reeves KD, Lam SK, et al. Treatment of temporomandibular dysfunction with hypertonic dextrose injection (prolotherapy): a randomized controlled trial with long-term partial crossover. Mayo Clin Proc. 2019 May 1;94(5):820–832. Elsevier. DOI:10.1016/j.mayocp.2018.07.023.
   PubMedGoogle Scholar
• ELwerfelli AM, Kalil AE, Abdullah NS. Clinical evaluation of dextrose prolotherapy for management of temporomandibular joint disorder. Alex Dent J 2019 Dec 1;44(3):1–7.
   Google Scholar
• Hassanien N, Kamel HM, Rashed SA. Dextrose prolotherapy versus low level laser therapy (LLLT) for management of temporomandibular joint disorders (TMD): clinical randomized controlled study. Egypt Dent J. 2020 Jan 1;66:95–106. DOI:10.21608/edj.2020.77519.
   Google Scholar
• Zarate MA, Frusso RD, Reeves KD, et al. Dextrose prolotherapy versus lidocaine injection for temporomandibular dysfunction: a pragmatic randomized controlled trial. J Altern Complement Med 2020 Nov 1;26(11):1064–1073.
   PubMedGoogle Scholar
• Priyadarshini S, Gnanam A, Sasikala B, et al. Evaluation of prolotherapy in comparison with occlusal splints in treating internal derangement of the temporomandibular joint–A randomized controlled trial. J Craniomaxillofac Surg 2021 Jan 1;49(1):24–28.
   PubMedGoogle Scholar
• Haggag MA, Al-Belasy FA, Ahmed WM. Dextrose prolotherapy for pain and dysfunction of the TMJ reducible disc displacement: a randomized, double-blind clinical study. J Craniomaxillofac Surg. 2022 Mar 8;50:426–431. DOI:10.1016/j.jcms.2022.02.009.
   PubMedGoogle Scholar
• Mori H, Bagul S, Chandan S. The efficacy of prolotherapy in temporomandibular dysfunction: a prospective study. J Oral Maxillofac Surg. 2021 Apr;21:1–8.
   Google Scholar
• Dasukil S, Shetty SK, Arora G, et al. Efficacy of prolotherapy in temporomandibular joint disorders: an exploratory study. J Oral Maxillofac Surg. 2021 Mar;20(1):115–120.
   Google Scholar
• Dasukil S, Arora G, Shetty S, et al. Impact of prolotherapy in temporomandibular joint disorder: a quality of life assessment. Br J Oral Maxillofac Surg 2021 Jun 1;59(5):599–604.
   PubMedGoogle Scholar
• Zhou H, Xue Y, Liu P. Application of auriculotemporal nerve block and dextrose prolotherapy in exercise therapy of TMJ closed lock in adolescents and young adults. Head Face Med. 2021 Dec;17(1):1–7.
   PubMedGoogle Scholar
• Hauser RA, Hauser MA, Blakemore KA. Dextrose prolotherapy and pain of chronic TMJ dysfunction. Pract Pain Manag. 2007;7(9):49–57.
   Google Scholar
• Hauser R. The regeneration of articular cartilage with prolotherapy. J Prolother. 2009;1(1):39–44.
   Google Scholar
• Banks A. A rationale for prolotherapy. J Orthop Med. 1991;13(3):54–59.
   Google Scholar
• Mobasheri A. Glucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator. Front Endocrinol. 2012 Dec 17;3:153.
   PubMedGoogle Scholar
• Wu TJ, Fong YC, Lin CY, et al. Glucose enhances aggrecan expression in chondrocytes via the PKCα/p38‐miR141‐3p signaling pathway. J Cell Physiol. 2018 Sep;233(9):6878–6887.
   PubMedGoogle Scholar
• Burdakov D, Jensen LT, Alexopoulos H, et al. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron 2006 Jun 1;50(5):711–722.
   PubMedGoogle Scholar
• Malek N, Pajak A, Kolosowska N, et al. The importance of TRPV1-sensitisation factors for the development of neuropathic pain. Mol Cell Neurosci. 2015 Mar 1;65:1.
   PubMedGoogle Scholar
• Bertrand H, Kyriazis M, Reeves KD, et al. Topical mannitol reduces capsaicin-induced pain: results of a pilot-level, double-blind, randomized controlled trial. PM&R 2015 Nov 1;7(11):1111–1117.
   Web of Science ®Google Scholar
• MacIver MB, Tanelian DL. Activation of C fibers by metabolic perturbations associated with tourniquet ischemia. Anesthesiology 1992 Apr 1;76(4):617–623.
   PubMedGoogle Scholar
• Nakashima T, Ogawa Y, Kimura A, et al. Coadministration of 5% glucose solution has a decrease in bendamustine-related vascular pain grade. J Oncol Pharm Pract. 2012 Dec;18(4):445–447.
   PubMedGoogle Scholar
• Maniquis-Smigel L, Reeves KD, Rosen HJ, et al. Short term analgesic effects of 5% dextrose epidural injections for chronic low back pain: a randomized controlled trial. Anesth Pain Med. 2017 Feb;7(1):1–8.
   Google Scholar
• Champs B, Corre P, Hamel A, et al. US-guided temporomandibular joint injection: validation of an in-plane longitudinal approach. J Stomatol Oral Maxillofac Surg 2019 Feb 1;120(1):67–70.
   PubMedGoogle Scholar
• Al-Delayme RE, Alnuamy SH, Hamid FT, et al. The efficacy of platelets rich plasma injection in the superior joint space of the temporomandibular joint guided by ultra sound in patients with non-reducing disk displacement. J Oral Maxillofac Surg. 2017 Mar;16(1):43–47.
   Google Scholar
• Orhan K, Rozylo-Kalinowska I. Ultrasonography-guided invasive procedures of the temporomandibular joint. Clin Dent Rev. 2021 Dec;5(1):1–11.
   Google Scholar